Meeting on EU fundings for start-ups in molecular technologies

February 27, 2014

Pgm2014 2020: Yes

Text:

Founding a company in the fields of chemistry and the life sciences is not only associated with high initial investments for good equipment but it also requires capable minds to develop scientific ideas into marketable products. Many scientists at universities and other research institutions dream about a company but there are many hurdles to overcome to achieve such objective. From the basic scientific intuition to the establishment of a “new technology company“ able to attract customers, find suitable suppliers, hire an appropriate workforce, etc., a rigorous business plan is needed and investment capital is required to launch the start-up.

COST (European Cooperation in Science and Technology) is an ideal platform for addressing these challenges because it is based on networking at the interface of science and technology. The special profile of CMST (Chemistry and Molecular Sciences and Technologies) at the interface of biology, pharmacy, medicine, and materials pushes this COST Domain to take on the challenge and organize a public event thanks to its location at the frontier of modern technology and innovation. In summary, an event of this type including scientists with entrepreneurship ideas, stakeholders and policy makers will fit ideally within Horizon 2020.

The event will provide background information on legal issues, managing skills, business-oriented networking, venture capital, policy mechanisms and it should stimulate technology transfer from COST Actions. During the event successful examples of spin-off created or working within CMST Actions will be showcased.